Suppr超能文献

预测天然化合物作为 SARS-CoV-2 结构蛋白的潜在多靶抑制剂。

prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2.

机构信息

Department of Biomedical Science, Acharya Narendra Dev College, University of Delhi, New Delhi, India.

G N Ramachandran Knowledge of Centre, Council of Scientific and Industrial Research - Institute of Genomics and Integrative Biology (CSIR-IGIB), New Delhi, India.

出版信息

J Biomol Struct Dyn. 2022;40(22):12118-12134. doi: 10.1080/07391102.2021.1968497. Epub 2021 Sep 6.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a colossal loss to human health and lives and has deeply impacted socio-economic growth. Remarkable efforts have been made by the scientific community in containing the virus by successful development of vaccines and diagnostic kits. Initiatives towards drug repurposing and discovery have also been undertaken. In this study, we compiled the known natural anti-viral compounds using text mining of the literature and examined them against four major structural proteins of SARS-CoV-2, namely, spike (S) protein, nucleocapsid (N) protein, membrane (M) protein and envelope (E) protein. Following computational approaches, we identified fangchinoline and versicolactone C as the compounds to exhibit strong binding to the target proteins and causing structural deformation of three structural proteins (N, S and M). We recommend the inhibitory effects of these compounds from our study should be experimentally validated against SARS-CoV-2.Communicated by Ramaswamy H. Sarma.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)对人类健康和生命造成了巨大损失,并对社会经济增长产生了深远影响。科学界通过成功开发疫苗和诊断试剂盒,为控制该病毒做出了巨大努力。药物再利用和发现的举措也已经展开。在这项研究中,我们使用文献的文本挖掘技术编译了已知的天然抗病毒化合物,并针对 SARS-CoV-2 的四种主要结构蛋白(刺突(S)蛋白、核衣壳(N)蛋白、膜(M)蛋白和包膜(E)蛋白)对它们进行了检测。通过计算方法,我们确定汉防己甲素和冬凌草甲素 C 是能够与靶蛋白强烈结合并导致三种结构蛋白(N、S 和 M)结构变形的化合物。我们建议,应通过实验验证这些化合物对 SARS-CoV-2 的抑制作用。由 Ramaswamy H. Sarma 交流。

相似文献

1
prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2.
J Biomol Struct Dyn. 2022;40(22):12118-12134. doi: 10.1080/07391102.2021.1968497. Epub 2021 Sep 6.
2
Plant-derived active compounds as a potential nucleocapsid protein inhibitor of SARS-CoV-2: an study.
J Biomol Struct Dyn. 2023 Jul;41(10):4770-4785. doi: 10.1080/07391102.2022.2072951. Epub 2022 May 9.
3
identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase.
J Biomol Struct Dyn. 2022 Sep;40(14):6534-6544. doi: 10.1080/07391102.2021.1886174. Epub 2021 Feb 15.
4
In silico bioprospecting of antiviral compounds from marine fungi and mushroom for rapid development of nutraceuticals against SARS-CoV-2.
J Biomol Struct Dyn. 2023 Mar;41(5):1574-1585. doi: 10.1080/07391102.2021.2023048. Epub 2021 Dec 31.
5
In silico evaluation of the inhibitory potential of nucleocapsid inhibitors of SARS-CoV-2: a binding and energetic perspective.
J Biomol Struct Dyn. 2023 Nov;41(19):9797-9807. doi: 10.1080/07391102.2022.2146752. Epub 2022 Nov 15.
6
investigation of some recent natural compounds for their potential use against SARS-CoV-2: a DFT, molecular docking and molecular dynamics study.
J Biomol Struct Dyn. 2023 Apr;41(6):2448-2465. doi: 10.1080/07391102.2022.2033136. Epub 2022 Jan 28.
7
Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
J Biomol Struct Dyn. 2022 Jul;40(10):4532-4542. doi: 10.1080/07391102.2020.1860133. Epub 2020 Dec 11.

引用本文的文献

3
Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms.
Arch Pharm Res. 2022 Dec;45(12):909-937. doi: 10.1007/s12272-022-01420-3. Epub 2022 Nov 28.
5
Phytovid19: a compilation of phytochemicals research in coronavirus.
Struct Chem. 2022;33(6):2169-2177. doi: 10.1007/s11224-022-02035-6. Epub 2022 Aug 25.
6
The Molecular Basis of the Effect of Temperature on the Structure and Function of SARS-CoV-2 Spike Protein.
Front Mol Biosci. 2022 Mar 25;9:794960. doi: 10.3389/fmolb.2022.794960. eCollection 2022.
7
Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor.
Front Immunol. 2022 Jan 14;12:794780. doi: 10.3389/fimmu.2021.794780. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验